國家衛生研究院 NHRI:Item 3990099045/10757

NHRI > Institute of Population Health Sciences > Hui-Ju Tsai > Conference Papers/Meeting Abstract > Item 3990099045/10757

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/10757

Title:	Increased risk of developing depressive and anxiety disorders in patients with systemic lupus erythematosus:A matched case-control study
Authors:	Lu, K;Lo, Y;Tsai, Y;Yao, T;Tsai, H
Contributors:	Institute of Population Health Sciences
Abstract:	Introduction: Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease that may involve the central nervous system, which is known as neuropsychiatric SLE. Both depressive and anxiety disorders have been reported as comorbidities of SLE, but the relationship remains controversial. Objectives: The aim of this study was to evaluate the risk of developing depressive and/or anxiety disorders in patients with SLE. We performed a matched case-control study using data from the Longitudinal Health Insurance Database 2000, 2005, and 2010 (LHID2000, LHID2005 and LHID2010, respectively), which are part of National Health Insurance Research Database (NHIRD). Study subjects were diagnosed as SLE during our study period (from the start of 2002 to the end of 2010), without psychiatric diagnoses before enrollment. Proportional hazard analyses with and without important covariates were applied to determine the relationship between SLE and depressive and/or anxiety disorders. Results: We identified 904 SLE patients and age-, gender-matched 4,520 controls in this study. We found a significantly increased risk of depressive and/or anxiety disorders (adjusted hazards ratio (HR): 1.79; 95% confidence interval (CI): 1.08-2.97). Conclusions: To our knowledge, this is one of the few studies reporting a significantly increased risk of depressive and/or anxiety disorders in patients with SLE after adjusting for important risk factors in a national healthcare database. The findings suggest SLE is a significant risk factor for the development of depressive and/or anxiety disorders. Further investigation on underlying mechanisms will be warranted.
Date:	2017-08
Relation:	Allergy. 2017 Aug;72(Suppl. 103, SI):755.
Link to:	http://dx.doi.org/10.1111/all.13252
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0105-4538&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000408773104323
Appears in Collections:	[Hui-Ju Tsai] Conference Papers/Meeting Abstract

Files in This Item:

File	Description	Size	Format
ISI000408773104323.pdf		61Kb	Adobe PDF	379	View/Open

Loading...